Lyophilised · ≥99% (HPLC) ·
Supplied lyophilised. Reconstitution typically uses bacteriostatic water.
AOD-9604 (Anti-Obesity Drug 9604) is a synthetic 16-amino-acid peptide fragment corresponding to the C-terminal region (Tyr-hGH177–191) of human growth hormone, modified with a tyrosine residue at the N-terminus to enhance stability; CAS 221231-10-3; molecular formula C78H123N23O23S2; molecular weight 1815.1 g/mol; studied in adipogenesis, lipolysis regulation, and metabolic research models. Supplied lyophilised at HPLC ≥99% purity. For laboratory research use only; not for human or veterinary use.
Derived from the very tail of the human growth-hormone molecule, AOD-9604 is a synthetic peptide fragment corresponding to the C-terminal lipolytic domain of hGH (residues 177-191) with an added tyrosine and a stabilising disulfide bridge. It was designed around a simple hypothesis: that the fat-metabolising activity of growth hormone could be isolated from the rest of its signalling, and it has since become a reference compound in metabolic-peptide research.
One function, distilled from a larger hormone. Full-length growth hormone exerts many effects, of which lipid mobilisation is only one. Investigators mapped this lipolytic activity to the hormone's C-terminal region and synthesised the corresponding fragment to probe it in isolation (Ng et al., 2000). Because the peptide reproduces fat-metabolism signalling without acting through the classic IGF-1-raising pathway, it offered a cleaner experimental window into adipocyte regulation.
What the research explores. The fragment has been examined across metabolic and musculoskeletal models:
All such findings stem from in vitro and animal research; no human-use conclusions are implied. Full citations are listed under the Scientific References tab.
Physicochemical profile. CAS 221231-10-3 · Molecular formula C₇₈H₁₂₃N₂₃O₂₃S₂ · Molecular weight 1815.1 · Sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (Cys⁷–Cys¹⁴ disulfide) · Appearance: white lyophilized powder · Solubility: soluble in water.
Specification & quality. Each individually sealed vial contains 5 mg of AOD-9604 as a white lyophilized powder of ≥99% purity by HPLC. Every batch is third-party tested, with a Certificate of Analysis (COA) available. Store at −20 °C, protected from light and moisture. Shelf life: 24 months from the manufacture date.
This product is intended for laboratory research use only (RUO). It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application. Handling is restricted to qualified research professionals operating in an appropriately equipped laboratory.
Supplied for in-vitro laboratory research use only (RUO). Not a drug, food or supplement; not for human or veterinary use.
Certificate of Analysis — lot-specific COA ships with every order and is available on request.
Each lot is tested by an independent third-party laboratory for identity (mass spectrometry) and purity (HPLC). The Certificate of Analysis for your specific batch ships with the order and is available on request — no house data, no exceptions.
References are illustrative of the research literature surrounding this compound. All claims relate to in-vitro and animal models only.
AOD-9604 is a synthetic peptide fragment corresponding to the C-terminal lipolytic domain of human growth hormone (residues 177-191), with an added tyrosine and a stabilizing disulfide bridge. Unlike a secretagogue, it derives from the GH molecule itself. Condor Research supplies it as a 5 mg vial, ≥99% HPLC, strictly for in-vitro research use.
AOD-9604 reproduces only the C-terminal fragment (residues 177-191) of growth hormone that is associated with its lipolytic activity, rather than the signaling apparatus that triggers GH release. So it is a GH-derived fragment, not a secretagogue: it does not stimulate the GHRH or ghrelin receptors the way CJC-1295 or Ipamorelin do. It is a Research Use Only reference peptide.
They sit at different points of the GH axis. CJC-1295 is a GHRH-analogue secretagogue, modeled on the hormone that signals upstream to release growth hormone. AOD-9604 is instead a fragment of the GH molecule itself (residues 177-191), studied for the lipolytic domain. Both are supplied strictly as in-vitro research materials.
Tesamorelin is a GHRH analogue, a secretagogue-type molecule acting upstream of growth hormone. AOD-9604 is a fragment of the GH molecule itself (residues 177-191), studied as its lipolytic domain rather than as a release-stimulating signal. They are distinct research peptides addressing opposite ends of GH biology, both sold for in-vitro use only.
They represent different layers of the GH/IGF axis. AOD-9604 is a short fragment of growth hormone itself (residues 177-191). IGF-1 LR3 is a much larger 83-residue recombinant analogue of insulin-like growth factor-1, the downstream effector. So AOD-9604 sits at the GH level and IGF-1 LR3 at the IGF level. Both are Research Use Only reference materials.
AOD-9604 is a peptide fragment of growth hormone (residues 177-191), water-soluble and supplied as a lyophilate. SLU-PP-332 is a non-peptide small-molecule ERR agonist, soluble in DMSO. They are entirely different compound classes studied in metabolic research. Both are offered strictly as in-vitro reference materials, with no use protocols provided.
Each lot is tested by an independent third-party laboratory, with identity and purity confirmed by HPLC and mass spec, and ships with a batch-specific Certificate of Analysis certifying ≥99% purity. The listed sequence, disulfide bridge and molecular weight (1815.1) correspond to AOD-9604. To request the current lot COA, email info@condorresearch.com.
AOD-9604 is a water-soluble lyophilized powder, dissolved in a compatible aqueous diluent for in-vitro preparation, with volume chosen to reach the target analytical concentration from the 5 mg vial. Store the sealed vial at -20°C, protected from light (24-month shelf life). This is analytical preparation only; no human or veterinary dosing guidance is provided.
No — AOD-9604 is supplied strictly as a Research Use Only (in vitro) reference material: not a medicine, supplement or medical device, and not for human or veterinary administration or consumption. Sales are restricted to professionals and institutions aged 18+. Buyers are responsible for confirming the legality of import in their own jurisdiction.
Reconstitution was clean with no visible particulates. The lot-specific COA matched the assay we ran in-house — purity is exactly as stated.
We verify every incoming compound by HPLC; this batch came back within tolerance of the certificate. Dispatch from the EU warehouse was quick.
Cold-chain handling was respected end to end. Vials arrived sealed, labelled and intact. Documentation is the most thorough I've seen from an EU supplier.
Solubility and stability were as described. Knocked one star only because express shipping options are limited, but quality is not in question.
Cookies
We use strictly necessary cookies to run the store. With your consent we also use analytics (order attribution) and marketing (Omnisend) cookies. Read our Cookie Policy.